Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neema Mturi

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Nature Communications|March 11, 2018
Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4James J Gilchrist, Anna Rautanen, Benjamin P Fairfax, et al.
Elife|April 26, 2018
Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α<sup>+</sup>thalassaemiaD Herbert Opi, Olivia Swann, Alexander Macharia, et al.
Lancet (London, England)|April 20, 2019
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance studyLaura L Hammitt, Anthony O Etyang, Susan C Morpeth, et al.
The New England Journal of Medicine|December 10, 2008
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of agePhilip Bejon, John Lusingu, Ally Olotu, et al.
The Lancet. Infectious Diseases|June 10, 2021
Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trialMainga Hamaluba, Rob W van der Pluijm, Joseph Weya, et al.
The Lancet. Infectious Diseases|January 18, 2011
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialAlly Olotu, John Lusingu, Amanda Leach, et al.
BMC Medicine|January 27, 2022
Malaria hospitalisation in East Africa: age, phenotype and transmission intensityAlice Kamau, Robert S Paton, Samuel Akech, et al.
Science Advances|March 28, 2017
Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsisLiuyang Wang, Emily R Ko, James J Gilchrist, et al.
Plos One|December 3, 2010
Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian ChildrenJohn Lusingu, Ally Olotu, Amanda Leach, et al.
Nature Microbiology|August 31, 2016
Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal KenyaAnna C Seale, Angela C Koech, Anna E Sheppard, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Nature Communications|March 11, 2018
Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4James J Gilchrist, Anna Rautanen, Benjamin P Fairfax, et al.
Elife|April 26, 2018
Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α<sup>+</sup>thalassaemiaD Herbert Opi, Olivia Swann, Alexander Macharia, et al.
Lancet (London, England)|April 20, 2019
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance studyLaura L Hammitt, Anthony O Etyang, Susan C Morpeth, et al.
The New England Journal of Medicine|December 10, 2008
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of agePhilip Bejon, John Lusingu, Ally Olotu, et al.
The Lancet. Infectious Diseases|June 10, 2021
Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trialMainga Hamaluba, Rob W van der Pluijm, Joseph Weya, et al.
The Lancet. Infectious Diseases|January 18, 2011
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialAlly Olotu, John Lusingu, Amanda Leach, et al.
BMC Medicine|January 27, 2022
Malaria hospitalisation in East Africa: age, phenotype and transmission intensityAlice Kamau, Robert S Paton, Samuel Akech, et al.
Science Advances|March 28, 2017
Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsisLiuyang Wang, Emily R Ko, James J Gilchrist, et al.
Plos One|December 3, 2010
Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian ChildrenJohn Lusingu, Ally Olotu, Amanda Leach, et al.
Nature Microbiology|August 31, 2016
Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal KenyaAnna C Seale, Angela C Koech, Anna E Sheppard, et al.
Pageof 7